LAUREN POLICKY: Open Payments
NPI 1427582576 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,497 in 21 payments from 12 companies in 2025. Trend: 2023 $67 · 2024 $148 · 2025 $1,497
Travel & lodging: $862Food & beverage: $560Education: $75
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 7 | $1,131 |
| Novartis Pharmaceuticals Corporation | 2 | $94 |
| SANOFI-AVENTIS U.S. LLC | 1 | $75 |
| ABBVIE INC. | 2 | $38 |
| Lilly USA, LLC | 2 | $28 |
| Ipsen Biopharmaceuticals, Inc | 1 | $24 |
| Iovance Biotherapeutics, Inc. | 1 | $22 |
| PFIZER INC. | 1 | $21 |
| Eisai Inc. | 1 | $17 |
| Karyopharm Therapeutics Inc. | 1 | $16 |
Products named: KISQALI, SARCLISA, VERZENIO, Onivyde, Amtagvi, TIVDAK, LUPRON DEPOT, Lenvima.
Industry payments across NE — which companies pay providers there.
